Neurogene Inc. (NASDAQ: NGNE)
$45.74
-0.2100 ( -0.46% ) 90.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$45.74
Previous close
$45.95
Volume
90.0K
Market cap
$593.85M
Day range
$44.25 - $47.31
52 week range
$12.49 - $53.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 2 | Jan 18, 2024 |
| 8-k | 8K-related | 49 | Jan 05, 2024 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 4 | Insider transactions | 1 | Dec 20, 2023 |
| 8-k | 8K-related | 41 | Dec 19, 2023 |